Globus Medical Inc  

(Public, NYSE:GMED)   Watch this stock  
Find more results for GMED
-1.39 (-5.57%)
Jan 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 23.15 - 24.98
52 week 17.45 - 27.14
Open 24.77
Vol / Avg. 928,531.00/334,536.00
Mkt cap 2.23B
P/E 26.21
Div/yield     -
EPS 0.90
Shares 94.48M
Beta     -
Inst. own 64%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 19.58% 15.79%
Operating margin 29.65% 23.40%
EBITD margin - 33.46%
Return on average assets 14.63% 13.54%
Return on average equity 17.10% 15.98%
Employees 850 -
CDP Score - -


United States - Map
+1-610-9301800 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Globus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company's products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.

Officers and directors

David C. Paul Chairman of the Board, Chief Executive Officer
Age: 47
David M. Demski President, Chief Operating Officer, Director
Age: 56
A. Brett Murphy Executive Vice President, US Sales
Age: 49
David D. Davidar Senior Vice President - Operations , Director
Age: 48
Steven M. Payne Chief Accounting Officer
Age: 43
Daniel T. Lemaitre Independent Director
Age: 60
Robert W. Liptak Independent Director
Age: 50
Ann D. Rhoads Independent Director
Age: 48
Kurt C. Wheeler Independent Director
Age: 61